B Braun Medical Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for B BRAUN MEDICAL INC, and when can generic versions of B BRAUN MEDICAL INC drugs launch?
B BRAUN MEDICAL INC has eleven approved drugs.
There are two US patents protecting B BRAUN MEDICAL INC drugs.
There are twenty-seven patent family members on B BRAUN MEDICAL INC drugs in twenty-seven countries and fifty-eight supplementary protection certificates in fifteen countries.
Summary for B Braun Medical Inc
International Patents: | 27 |
US Patents: | 2 |
Tradenames: | 11 |
Ingredients: | 10 |
NDAs: | 11 |
Drug Master File Entries: | 21 |
Drugs and US Patents for B Braun Medical Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B Braun Medical Inc | CALCIUM GLUCONATE | calcium gluconate | SOLUTION;INTRAVENOUS | 216541-001 | Aug 21, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
B Braun Medical Inc | MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER | meropenem | POWDER;INTRAVENOUS | 202106-001 | Apr 30, 2015 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
B Braun Medical Inc | MAGNESIUM SULFATE | magnesium sulfate | INJECTABLE;INJECTION | 207967-002 | Apr 26, 2021 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for B Braun Medical Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Italy | MI20122120 | ⤷ Try a Trial |
Australia | 2013356855 | ⤷ Try a Trial |
Portugal | 1931304 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for B Braun Medical Inc Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2603514 | 132019000000051 | Italy | ⤷ Try a Trial | PRODUCT NAME: COMBINAZIONE DI VABORBACTAM E/O UN SUO SALE E/O UN SUO IDRATO, E MEROPENEM, E/O UN SUO SALE E/O UN SUO IDRATO, IN PARTICOLARE MEROPENEM TRIIDRATO(VABOMERE); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/18/1334, 20181122 |
0984957 | CR 2012 00035 | Denmark | ⤷ Try a Trial | PRODUCT NAME: ET KOMBINATIONSPRODUKT AF NAPROXEN OG ESOMEPRAZOL MAGNESIUM TRIHYDRAT; NAT. REG. NO/DATE: 49583 20120327; FIRST REG. NO/DATE: GB PL 17901/0263-001 20101105 |
0984957 | 1290006-4 | Sweden | ⤷ Try a Trial | PRODUCT NAME: ACETYLSALICYLSYRA OCH ESOMEPRAZOLMAGNESIUMTRIHYDRAT; NAT. REG. NO/DATE: MTNR 44371 20110930; FIRST REG.: PT 5402359MFL 20110812 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.